REMICADE® is a biologic treatment with more than 1.3 million treated across all uses around the world—and has 18 years of clinical trial experience.

X

For adults with moderately to severely active Crohn's disease who haven't responded well to other therapies  

About REMICADE®

Learn about the proven results of REMICADE® treatment.

Managing Treatment

Download the Appointment Guide or read questions you may want to ask your gastroenterologist about your moderately to severely active Crohn's disease.

Video Center

Hear from people who are living with—and doctors who are treating— moderately to severely active Crohn’s disease.

Medication Cost Support

You may be eligible for the RemiStart® Patient Rebate Program.

X

For children ages 6-17 with moderately to severely active pediatric Crohn's disease who haven't responded well to other therapies  

About REMICADE®

Learn about REMICADE® for moderately to severely active Crohn's disease in children 6 years and older.

For Children >6 Years Old and Teens

Information just for you about moderately to severely active pediatric Crohn's disease and what to expect with REMICADE® treatment.

Managing Treatment

Download the Appointment Guide or read questions you may want to ask your child's gastroenterologist about moderately to severely active pediatric Crohn's disease.

Medication Cost Support

You may be eligible for the RemiStart® Patient Rebate Program.

X

For adults with moderately to severely active ulcerative colitis who haven't responded well to other therapies  

About REMICADE®

Learn about the proven results of REMICADE® treatment.

Managing Treatment

Download the Appointment Guide or read questions you may want to ask your gastroenterologist about your moderately to severely active ulcerative colitis.

Video Center

Hear from people who are living with—and doctors who are treating— moderately to severely active ulcerative colitis.

Medication Cost Support

You may be eligible for the RemiStart® Patient Rebate Program.

X

For children ages 6-17 with moderately to severely active pediatric ulcerative colitis who haven't responded well to other therapies  

About REMICADE®

Learn about REMICADE® for moderately to severely active ulcerative colitis in children 6 years and older.

For Children >6 Years Old and Teens

Information just for you about moderately to severely active pediatric ulcerative colitis and what to expect with REMICADE® treatment.

Managing Treatment

Download the Appointment Guide or read questions you may want to ask your child's gastroenterologist about moderately to severely active pediatric ulcerative colitis.

Medication Cost Support

You may be eligible for the RemiStart® Patient Rebate Program.

X

For adults with moderately to severely active rheumatoid arthritis  

Why REMICADE®?

Learn how REMICADE® can help.

Customized Dosing

Dosing is based on your individual weight, and can be adjusted if you continue to have symptoms. Increased doses may be associated with an increased risk of infections.

REMICADE® Stories

Hear from people who have been treated with REMICADE®.

Medication Cost Support

You may be eligible for the RemiStart® Patient Rebate Program.

X

For adults with active psoriatic arthritis  

Why REMICADE®?

Learn how REMICADE® can help.

Customized Dosing

REMICADE® dosing is customized for you, based on your individual weight.

REMICADE® Stories

Hear from people who have been treated with REMICADE®.

Medication Cost Support

You may be eligible for the RemiStart® Patient Rebate Program.

X

For adults with active ankylosing spondylitis  

Why REMICADE®?

Learn how REMICADE® can help.

Customized Dosing

REMICADE® dosing is customized for you, based on your individual weight.

Getting Started

See how to prepare for REMICADE® infusions.

Medication Cost Support

You may be eligible for the RemiStart® Patient Rebate Program.

X

For adults with chronic severe plaque psoriasis  

About REMICADE®

Learn about the proven results of REMICADE® treatment.

REMICADE® Stories

Hear from people who have been treated with REMICADE®.

Doctor Discussion Guide

Download a doctor discussion guide to help you talk to your doctor about your plaque psoriasis symptoms.

Medication Cost Support

You may be eligible for the RemiStart® Patient Rebate Program.

  • Moderately to Severely Active Crohn's Disease
  • Moderately to Severely Active Pediatric Crohn's Disease
  • Moderately to Severely Active Ulcerative Colitis
  • Moderately to Severely Active Pediatric Ulcerative Colitis
  • Moderately to Severely Active Rheumatoid Arthritis
  • Active Psoriatic Arthritis
  • Active Ankylosing Spondylitis
  • Chronic Severe Plaque Psoriasis

 

REMICADE® is a prescription medication used to treat:

Crohn's Disease
  • Can reduce signs and symptoms and induce and maintain remission in adult patients with moderately to severely active Crohn’s disease who haven't responded well to other therapies
Pediatric Crohn's Disease
  • Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active Crohn's disease who haven't responded well to other therapies
Ulcerative Colitis
  • Can reduce signs and symptoms, induce and maintain remission, promote intestinal healing, and reduce or stop the need for steroids in adult patients with moderately to severely active ulcerative colitis who haven't responded well to other therapies
Pediatric Ulcerative Colitis
  • Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active ulcerative colitis who haven’t responded well to other therapies
Rheumatoid Arthritis
  • Can reduce signs and symptoms, help stop further joint damage, and improve physical function in patients with moderately to severely active rheumatoid arthritis, in combination with methotrexate
Psoriatic Arthritis
  • Can reduce signs and symptoms of active arthritis, help stop further joint damage, and improve physical function in patients with psoriatic arthritis
Ankylosing Spondylitis
  • Can reduce signs and symptoms in patients with active ankylosing spondylitis
Plaque Psoriasis
  • Approved for the treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis under the care of a physician who will determine if REMICADE® is appropriate considering other available therapies

 

Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.

Unusual cancers have been reported in children and teenage patients taking TNF-blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in teenage or young adult males with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase.

You should discuss any concerns about your health and medical care with your doctor.

What should I tell my doctor before I take REMICADE®?

You should let your doctor know if you have or ever had any of the following:

  • Tuberculosis (TB) or have been near someone who has TB. Your doctor will check you for TB with a skin test. If you have latent (inactive) TB, you will begin TB treatment before you start REMICADE®.
  • Lived in a region where certain fungal infections like histoplasmosis or coccidioidomycosis are common.
  • Infections that keep coming back, have diabetes or an immune system problem.
  • Any type of cancer or a risk factor for developing cancer, for example, chronic obstructive pulmonary disease (COPD) or had phototherapy for psoriasis.
  • Heart failure or any heart condition. Many people with heart failure should not take REMICADE®.
  • Hepatitis B virus (HBV) infection or think you may be a carrier of HBV. Your doctor will test you for HBV.
  • Nervous system disorders (like multiple sclerosis or Guillain-Barré syndrome).

Also tell your doctor if you:

  • Use the medicines Kineret (anakinra), Orencia (abatacept) or Actemra (tocilizumab) or other medicines called biologics used to treat the same problems as REMICADE®.
  • Are pregnant, plan to become pregnant, are breast-feeding, or have a baby and were using REMICADE® during your pregnancy. Tell your baby’s doctor about your REMICADE® use before the baby receives any vaccine because of an increased risk of infection for up to 6 months after your last dose of REMICADE® you received during your pregnancy.
  • Recently received or are scheduled to receive a vaccine. Adults and children taking REMICADE® should not receive live vaccines or treatment with a weakened bacteria (such as BCG for bladder cancer) while taking REMICADE®.

What should I watch for and talk to my doctor about before or while taking REMICADE®?

The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.

You should tell your doctor right away if you have any of the signs listed below:

  • Infections (like TB, blood infections, pneumonia)—fever, tiredness, cough, flu, or warm, red or painful skin or any open sores. REMICADE® can make you more likely to get an infection or make any infection that you have worse.
  • Lymphoma, or any other cancers in adults and children.
  • Skin cancer—any changes in or growths on your skin.
  • Heart failure—new or worsening symptoms, such as shortness of breath, swelling of your ankles or feet, or sudden weight gain.
  • Reactivation of HBV—feeling unwell, poor appetite, tiredness, fever, skin rash and/or joint pain.
  • Liver injury—jaundice (yellow skin and eyes), dark brown urine, right-sided abdominal pain, fever, or severe tiredness.
  • Blood disorders—fever that doesn’t go away, bruising, bleeding or severe paleness.
  • Nervous system disorders—numbness, weakness, tingling, changes in your vision or seizures.
  • Allergic reactions during or after the infusion—hives, difficulty breathing, chest pain, high or low blood pressure, swelling of face and hands, and fever or chills.
  • Lupus-like syndrome—chest discomfort or pain that does not go away, shortness of breath, joint pain, rash on the cheeks or arms that gets worse in the sun.
  • Psoriasis—new or worsening psoriasis such as red scaly patches or raised bumps on the skin that are filled with pus.

The more common side effects with REMICADE® are respiratory infections (that may include sinus infections and sore throat), headache, rash, coughing and stomach pain.

Please read the Medication Guide for REMICADE® and discuss it with your doctor. (Requires Adobe® Acrobat® Reader®. Click here to download.)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.